We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00088179
Recruitment Status : Active, not recruiting
First Posted : July 23, 2004
Last Update Posted : February 16, 2017
Sponsor:
Collaborator:
Procter and Gamble
Information provided by:
Alexion Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : October 2005
  Study Completion Date : No date given
  Certification or Request for Extension to Delay Results Submission: February 15, 2017